Regeneron Pharmaceuticals, Inc. (REGN)
760.02
-3.02
(-0.40%)
USD |
NASDAQ |
Apr 07, 16:00
773.00
+12.98
(+1.71%)
After-Hours: 19:40
Regeneron Pharmaceuticals R&D to Revenue (TTM)
R&D to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D to Revenue Definition
The Research & Development (R&D) Expense to Revenue ratio measures the percentage of sales that is allocated to R&D expenditures. It is not as effective when looking at companies in different industries because different industries place different values on R&D. Technology companies and pharmaceutical companies are more likely to have high R&D ratios.
R&D to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median